116
Views
30
CrossRef citations to date
0
Altmetric
Drug Profile

Etravirine for the treatment of HIV infection

, &
Pages 427-433 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Bhushan M. Kapur, Janine R. Hutson, Tamanna Chibber, Adriana Luk & Peter Selby. (2011) Methadone: a review of drug-drug and pathophysiological interactions. Critical Reviews in Clinical Laboratory Sciences 48:4, pages 171-195.
Read now
Peng Zhan & Xinyong Liu. (2011) Novel HIV-1 non-nucleoside reverse transcriptase inhibitors: a patent review (2005 – 2010). Expert Opinion on Therapeutic Patents 21:5, pages 717-796.
Read now

Articles from other publishers (28)

Sonia Zeba Hashmi, Jaya Dwivedi, Dharma Kishore & Aleksey E. Kuznetsov. (2023) Synthesis, characterization, and DFT study of the s-triazine analogues of medicinal interest incorporated with five- and six-membered bioactive heterocyclic scaffolds. Journal of Molecular Structure 1278, pages 134922.
Crossref
Thanh Truong Giang Ly, Jisoo Yun, Jong-Seong Ha, Yeon-Ju Kim, Woong-Bi Jang, Thi Hong Van Le, Vinoth Kumar Rethineswaran, Jaewoo Choi, Jae-Ho Kim, Sang-Hyun Min, Dong-Hyung Lee, Ju-Seok Yang, Joo-Seop Chung & Sang-Mo Kwon. (2022) Inhibitory Effect of Etravirine, a Non-Nucleoside Reverse Transcriptase Inhibitor, via Anterior Gradient Protein 2 Homolog Degradation against Ovarian Cancer Metastasis. International Journal of Molecular Sciences 23:2, pages 944.
Crossref
Satish Rojekar, Leila Fotooh Abadi, Rohan Pai, Ketan Mahajan, Smita Kulkarni & Pradeep R Vavia. (2021) Multi-organ targeting of HIV-1 viral reservoirs with etravirine loaded nanostructured lipid carrier: An in-vivo proof of concept. European Journal of Pharmaceutical Sciences 164, pages 105916.
Crossref
Satish Rojekar, Lalitkumar K. Vora, Ismaiel A. Tekko, Fabiana Volpe-Zanutto, Helen O. McCarthy, Pradeep R. Vavia & Ryan F .Donnelly. (2021) Etravirine-loaded dissolving microneedle arrays for long-acting delivery. European Journal of Pharmaceutics and Biopharmaceutics 165, pages 41-51.
Crossref
Saikiran Reddy Peddi, Nihaya Abdulsattear Mohammed, Ammar Adil Hussein, Sree Kanth Sivan & Vijjulatha Manga. (2018) Multiple-receptor conformation docking, dock pose clustering, and 3D QSAR-driven approaches exploring new HIV-1 RT inhibitors. Structural Chemistry 29:4, pages 999-1012.
Crossref
Ana L.A. Godinho, Inês L. Martins, João Nunes, Catarina Charneira, Jorge Grilo, Diogo M. Silva, Sofia A. Pereira, Karina Soto, M. Conceição Oliveira, M. Matilde Marques, Cristina C. Jacob & Alexandra M.M. Antunes. (2018) High resolution mass spectrometry-based methodologies for identification of Etravirine bioactivation to reactive metabolites: In vitro and in vivo approaches. European Journal of Pharmaceutical Sciences 119, pages 70-82.
Crossref
Zhaoqiang Liu, Ye Tian, Jinghan Liu, Boshi Huang, Dongwei Kang, Erik De Clercq, Dirk Daelemans, Christophe Pannecouque, Peng Zhan & Xinyong Liu. (2017) Design, synthesis and anti-HIV evaluation of novel diarylpyridine derivatives as potent HIV-1 NNRTIs. European Journal of Medicinal Chemistry 140, pages 383-391.
Crossref
Camille Alam, Sana-Kay Whyte-Allman, Amila Omeragic & Reina Bendayan. (2016) Role and modulation of drug transporters in HIV-1 therapy. Advanced Drug Delivery Reviews 103, pages 121-143.
Crossref
Minlu Hu, Sravan Kumar Patel, Tian Zhou & Lisa C. Rohan. (2015) Drug transporters in tissues and cells relevant to sexual transmission of HIV: Implications for drug delivery. Journal of Controlled Release 219, pages 681-696.
Crossref
Xin Liu, Xuwang Chen, Lingzi Zhang, Peng Zhan & Xinyong Liu. (2015) 3D-QSAR and docking studies on piperidine-substituted diarylpyrimidine analogues as HIV-1 reverse transcriptase inhibitors. Medicinal Chemistry Research 24:8, pages 3314-3326.
Crossref
Liu Wang, Ye Tian, Wenmin Chen, Hong Liu, Peng Zhan, Dongyue Li, Huiqing Liu, Erik De Clercq, Christophe Pannecouque & Xinyong Liu. (2014) Fused heterocycles bearing bridgehead nitrogen as potent HIV-1 NNRTIs. Part 2: Discovery of novel [1,2,4]Triazolo[1,5-a]pyrimidines using a structure-guided core-refining approach. European Journal of Medicinal Chemistry 85, pages 293-303.
Crossref
Hai-Xia Jiang, Dao-Min Zhuang, Ying Huang, Xing-Xin Cao, Jian-Hua Yao, Jing-Yun Li, Jian-Yong Wang, Chen Zhang & Biao Jiang. (2014) Design, synthesis, and biological evaluation of novel trifluoromethyl indoles as potent HIV-1 NNRTIs with an improved drug resistance profile. Org. Biomol. Chem. 12:21, pages 3446-3458.
Crossref
Wenmin Chen, Peng Zhan, Erik De Clercq, Christophe Pannecouque, Jan Balzarini, Xin Jiang & Xinyong Liu. (2013) Design, synthesis and biological evaluation of N2,N4-disubstituted-1,1,3-trioxo-2H,4H-pyrrolo[1,2-b][1,2,4,6]thiatriazine derivatives as HIV-1 NNRTIs. Bioorganic & Medicinal Chemistry 21:22, pages 7091-7100.
Crossref
Peng Zhan, Xuwang Chen, Dongyue Li, Zengjun Fang, Erik De Clercq & Xinyong Liu. (2013) HIV-1 NNRTIs: structural diversity, pharmacophore similarity, and impliations for drug design. Medicinal Research Reviews 33:S1, pages E1-E72.
Crossref
Veronique Michaud, Tamara Bar-Magen, Jacques Turgeon, David Flockhart, Zeruesenay Desta & Mark A. Wainberg. (2012) The Dual Role of Pharmacogenetics in HIV Treatment: Mutations and Polymorphisms Regulating Antiretroviral Drug Resistance and Disposition. Pharmacological Reviews 64:3, pages 803-833.
Crossref
Xuwang Chen, Peng Zhan, Christophe Pannecouque, Jan Balzarini, Erik De Clercq & Xinyong Liu. (2012) Synthesis and biological evaluation of piperidine-substituted triazine derivatives as HIV-1 non-nucleoside reverse transcriptase inhibitors. European Journal of Medicinal Chemistry 51, pages 60-66.
Crossref
Dongyue Li, Peng Zhan, Erik De Clercq & Xinyong Liu. (2012) Strategies for the Design of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors: Lessons from the Development of Seven Representative Paradigms. Journal of Medicinal Chemistry 55:8, pages 3595-3613.
Crossref
Sofia A. Pereira, Riccardo Wanke, M. Matilde Marques, Emília C. Monteiro & Alexandra M.M. Antunes. 2012. Advances in Molecular Toxicology Volume 6. Advances in Molecular Toxicology Volume 6 1 39 .
Tracy L. Hartman, Lu Yang & Robert W. BuckheitJr.Jr.. (2011) Antiviral interactions of combinations of highly potent 2,4(1H,3H)-pyrimidinedione congeners and other anti-HIV agents. Antiviral Research 92:3, pages 505-508.
Crossref
L Bansi, C Sabin, V Delpech, T Hill, M Fisher, J Walsh, T Chadborn, P Easterbrook, R Gilson, M Johnson, K Porter, J Anderson, M Gompels, C Leen, J Ainsworth, C Orkin, M Nelson, B Rice & A Phillips. (2010) Trends over calendar time in antiretroviral treatment success and failure in HIV clinic populations * . HIV Medicine 11:7, pages 432-438.
Crossref
Tsutomu Murakami & Naoki Yamamoto. (2010) Role of CXCR4 in HIV infection and its potential as a therapeutic target. Future Microbiology 5:7, pages 1025-1039.
Crossref
Olena Kis, Kevin Robillard, Gary N.Y. Chan & Reina Bendayan. (2010) The complexities of antiretroviral drug–drug interactions: role of ABC and SLC transporters. Trends in Pharmacological Sciences 31:1, pages 22-35.
Crossref
Marie-Pierre de Béthune. (2010) Non-nucleoside reverse transcriptase inhibitors (NNRTIs), their discovery, development, and use in the treatment of HIV-1 infection: A review of the last 20 years (1989–2009). Antiviral Research 85:1, pages 75-90.
Crossref
Wendy S Stevens, Carole L Wallis, Ian Sanne & Francois Venter. (2009) Will Etravirine Work in Patients Failing Nonnucleoside Reverse Transcriptase Inhibitor-Based Treatment in Southern Africa?. JAIDS Journal of Acquired Immune Deficiency Syndromes 52:5, pages 655-656.
Crossref
Daniel Podzamczer Palter, Elena Ferrer Corbera & Juan Manuel Tiraboschi. (2009) Etravirina en pacientes ampliamente pretratados. Enfermedades Infecciosas y Microbiología Clínica 27, pages 6-11.
Crossref
Federico García García, Marta Álvarez Estévez & Vicente Guillot Suay. (2009) Características químicas, mecanismo de acción y actividad antiviral de etravirina. Enfermedades Infecciosas y Microbiología Clínica 27, pages 2-5.
Crossref
Anthony Ivetac & J. Andrew McCammon. (2009) Elucidating the Inhibition Mechanism of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors through Multicopy Molecular Dynamics Simulations. Journal of Molecular Biology 388:3, pages 644-658.
Crossref
Daryl S. Schiller & Manal Youssef-Bessler. (2009) Etravirine: A second-generation nonnucleoside reverse transcriptase inhibitor (NNRTI) active against NNRTI-resistant strains of HIV. Clinical Therapeutics 31:4, pages 692-704.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.